$UUU
UNIVERSAL SECURITY INSTRUMENTS INC

2015 Q3 Form 10-Q Financial Statement

#000114420415068931 Filed on December 02, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q3
Revenue $3.278M $2.224M
YoY Change 47.41% -30.41%
Cost Of Revenue $2.590M $1.730M
YoY Change 49.71% -27.62%
Gross Profit $684.7K $493.5K
YoY Change 38.73% -39.01%
Gross Profit Margin 20.88% 22.19%
Selling, General & Admin $1.154M $1.119M
YoY Change 3.09% 8.48%
% of Gross Profit 168.53% 226.79%
Research & Development $147.1K $260.0K
YoY Change -43.41% 175.09%
% of Gross Profit 21.49% 52.68%
Depreciation & Amortization $10.00K $10.00K
YoY Change 0.0% 0.0%
% of Gross Profit 1.46% 2.03%
Operating Expenses $1.301M $1.379M
YoY Change -5.67% 22.46%
Operating Profit -$616.3K -$885.7K
YoY Change -30.42% 179.32%
Interest Expense $210.0K -$230.0K
YoY Change -191.3% -195.83%
% of Operating Profit
Other Income/Expense, Net -$4.701K
YoY Change
Pretax Income -$4.701K $9.348K
YoY Change -150.29% -111.79%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings -$411.3K -$1.112M
YoY Change -63.02% -56.54%
Net Earnings / Revenue -12.55% -50.01%
Basic Earnings Per Share -$0.48
Diluted Earnings Per Share -$177.5K -$0.48
COMMON SHARES
Basic Shares Outstanding 2.313M shares 2.313M shares
Diluted Shares Outstanding 2.313M shares

Balance Sheet

Concept 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $150.0K $2.790M
YoY Change -94.62% 173.53%
Cash & Equivalents $148.8K $2.789M
Short-Term Investments
Other Short-Term Assets $340.0K $380.0K
YoY Change -10.53% 5.56%
Inventory $4.510M $2.842M
Prepaid Expenses $382.1K
Receivables $530.0K $298.3K
Other Receivables $1.480M $1.190M
Total Short-Term Assets $7.000M $7.633M
YoY Change -8.3% -21.33%
LONG-TERM ASSETS
Property, Plant & Equipment $90.00K $120.0K
YoY Change -25.0% -10.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.74M $13.92M
YoY Change -8.48% -7.26%
Other Assets $10.00K $40.00K
YoY Change -75.0% 4.89%
Total Long-Term Assets $12.90M $14.16M
YoY Change -8.88% -7.24%
TOTAL ASSETS
Total Short-Term Assets $7.000M $7.633M
Total Long-Term Assets $12.90M $14.16M
Total Assets $19.90M $21.79M
YoY Change -8.67% -12.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.310M $780.0K
YoY Change 67.95% 147.46%
Accrued Expenses $150.0K $290.0K
YoY Change -48.28% 81.25%
Deferred Revenue
YoY Change
Short-Term Debt $1.000M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.460M $1.070M
YoY Change 129.91% 83.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $25.00K
YoY Change -100.0% 0.0%
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $25.00K
YoY Change -100.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.460M $1.070M
Total Long-Term Liabilities $0.00 $25.00K
Total Liabilities $2.460M $1.100M
YoY Change 123.64% 81.13%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.44M $20.85M
YoY Change
Total Liabilities & Shareholders Equity $19.90M $21.95M
YoY Change -9.34% -12.06%

Cashflow Statement

Concept 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income -$411.3K -$1.112M
YoY Change -63.02% -56.54%
Depreciation, Depletion And Amortization $10.00K $10.00K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$680.0K -$170.0K
YoY Change 300.0% -76.71%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 570.0K
YoY Change
NET CHANGE
Cash From Operating Activities -680.0K -170.0K
Cash From Investing Activities 0.000
Cash From Financing Activities 570.0K
Net Change In Cash -110.0K -170.0K
YoY Change -35.29% -63.83%
FREE CASH FLOW
Cash From Operating Activities -$680.0K -$170.0K
Capital Expenditures $0.00
Free Cash Flow -$170.0K
YoY Change -76.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
74546 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
684657 USD
CY2015Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1001007 USD
CY2015Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3278225 USD
CY2014Q3 uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
1601148 USD
CY2015Q3 uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
2519022 USD
CY2014Q3 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
129279 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
493516 USD
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-235902 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1837423 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2306735 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2317616 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6214715 USD
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
10236562 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23472 USD
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
209700 USD
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2312887 shares
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
259982 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
147128 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1119244 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1153830 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-885710 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-616301 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-1112264 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-411302 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-532516 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2788927 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
12983 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2312887 shares
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
6312 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-248429 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-77433 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2312887 shares
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-443247 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4701 USD
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2312887 shares
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1313839 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9348 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2223943 USD
uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
3312147 USD
uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
4504825 USD
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
321177 USD
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
142806 USD
us-gaap Gross Profit
GrossProfit
1105004 USD
us-gaap Gross Profit
GrossProfit
1567084 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
421946 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
347431 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1623677 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1097963 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16993 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12983 USD
us-gaap Net Income Loss
NetIncomeLoss
-1855113 USD
us-gaap Net Income Loss
NetIncomeLoss
-1188379 USD
CY2015Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2014Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-27490 USD
CY2015Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-31945 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1133442 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-20396 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
38086 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-125460 USD
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
8520500 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18769 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
311484 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1533523 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
11705386 USD
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-668805 USD
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
217597 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
284984 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
737934 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
737934 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2050993 USD
uuu Increase Decrease In Inventories And Prepaid Expenses
IncreaseDecreaseInInventoriesAndPrepaidExpenses
535233 USD
uuu Increase Decrease In Inventories And Prepaid Expenses
IncreaseDecreaseInInventoriesAndPrepaidExpenses
-1367357 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1001007 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
2214351 USD
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
1477303 USD
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
17222188 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-23079 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-858588 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
31239508 USD
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
34811711 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
5494185 USD
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
7448715 USD
uuu Products Purchased From Joint Venture
ProductsPurchasedFromJointVenture
2424356 USD
CY2015Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.5 pure
CY2015Q3 us-gaap Line Of Credit
LineOfCredit
1001007 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000102109
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
593580 USD
CY2015Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
571012 USD
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
The agreement replaces the financing and factoring agreement with CIT which was terminated on the same date. In accordance with the provisions of the Discount Factoring Agreement with Merchant, the Company may take advances, recorded as a liability of the Company, equal to eighty percent (80%) of the factored trade accounts receivable balance less applicable factoring commissions. Additionally, the Discount Factoring Agreement with Merchant enables the Company to borrow up to fifty percent (50%) of eligible inventories subject to a borrowing limitation on inventory of $1,000,000.
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31945 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-21178 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-125460 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17690 USD
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
7448715 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
5494185 USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1001007 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2015Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
299985 USD
CY2015Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
752789 USD
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2015 us-gaap Net Income Loss
NetIncomeLoss
3704985 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
4450244 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1000000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.80
uuu Products Purchased From Joint Venture
ProductsPurchasedFromJointVenture
4853808 USD
uuu Increase Or Decrease In Inter Company Profit In Inventory
IncreaseOrDecreaseInInterCompanyProfitInInventory
171224 USD
CY2015 uuu Increase Or Decrease In Inter Company Profit In Inventory
IncreaseOrDecreaseInInterCompanyProfitInInventory
-180865 USD

Files In Submission

Name View Source Status
0001144204-15-068931-index-headers.html Edgar Link pending
0001144204-15-068931-index.html Edgar Link pending
0001144204-15-068931.txt Edgar Link pending
0001144204-15-068931-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tex99-1logo.jpg Edgar Link pending
uuu-20150930.xml Edgar Link completed
uuu-20150930.xsd Edgar Link pending
uuu-20150930_cal.xml Edgar Link unprocessable
uuu-20150930_def.xml Edgar Link unprocessable
uuu-20150930_lab.xml Edgar Link unprocessable
uuu-20150930_pre.xml Edgar Link unprocessable
v423241_10q.htm Edgar Link pending
v423241_ex31-1.htm Edgar Link pending
v423241_ex31-2.htm Edgar Link pending
v423241_ex32-1.htm Edgar Link pending
v423241_ex99-1.htm Edgar Link pending